You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Silbersher v. Allergan plc (N.D. Cal. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Silbersher v. Allergan plc
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Silbersher v. Allergan plc (N.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2020-12-10 135 Order on Motion to Dismiss Relator relies is a single patent, U.S. Patent No. 8,039,009 (“the ’009 patent”). Id. ¶ 91. Relator … The first category of patents is the Went Patents, a group of eleven patents that list Dr. … 6 The parent patent for all of the Went Patents is the ’291 patent, which was issued on … The Went Patents are U.S. Patent Nos. 8,058,291 (“the ’291 patent”); 8,168,209, as …corrected (“the ’209 patent”); 8,173,708 (“the ’708 patent”); 8,283,379 (“the ’379 patent”); External link to document
2023-03-13 194 Order on Motion to Dismiss Relator relies is a single patent, U.S. Patent No. 8,039,009 (“the ’009 patent”). Id. ¶ 91. Relator … The first category of patents is the Went Patents, a group of eleven patents that list Dr. … 9 The parent patent for all of the Went Patents is the ’291 patent, which was issued on … The Went Patents are U.S. Patent Nos. 8,058,291 (“the ’291 patent”); 8,168,209, as …corrected (“the ’209 patent”); 8,173,708 (“the ’708 patent”); 8,283,379 (“the ’379 patent”); External link to document
2023-03-20 197 Order Relator relies is a single patent, U.S. Patent No. 8,039,009 (“the ’009 patent”). Id. ¶ 91. Relator … The first category of patents is the Went Patents, a group of eleven patents that list Dr. … 19 The parent patent for all of the Went Patents is the ’291 patent, which was issued on … The Went Patents are U.S. Patent Nos. 8,058,291 (“the ’291 patent”); 8,168,209, as …corrected (“the ’209 patent”); 8,173,708 (“the ’708 patent”); 8,283,379 (“the ’379 patent”); External link to document
2019-06-14 63 Motion to Dismiss Went 18 patents (U.S. Patent No. 8,362,085) on anticipation and obviousness … allegations about the remaining patents (the so-called “Went patents”) fail as 11 to the… 27 push-and-pull of the patent system. Resolution of complex patent validity and enforceability issues… • ’009 Patent. Relator also alleges that, in connection with a separate patent, Forest Labs …refers to a ’703 patent in multiple places, but concedes that that patent “has not blocked External link to document
2019-06-21 68 Dismiss eleven Went Patents. AC ¶ 58. In addition, the Orange Book lists U.S. Patent No. 8,039,009 (the … U.S. Patent No. 8,173,708 (the ‘“708 patent”); U.S. Patent No. 8,293,379 (the “‘379 patent”); U.S. … 16 Patent No. 8,293,794 (the “‘794 patent”); U.S. Patent No. 8,362,085 (the “085 patent”); and U.S… patent, the ‘794 patent, the ‘085 patent, and the ‘233 9 patent, is unenforceable… 17 Patent No. 8,598,233 (the “‘233 patent”). AC ¶¶ 57-58. These six patents are among a group External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.